Applications of Artificial Cells in Medicine and Biotechnology

References

• Chang T MS. Hemoglobin corpuscles. Report of research project for Honours B.Sc. McGill University. 1957
   Google Scholar
• Chang T MS. Semipermeable microcapsules. Science 1964; 14b: 524
   Google Scholar
• Chang T MS, Macintosh F C, Mason S G. Semipermeable Microcapsules: I. Preparation and properties. Can J Physiol Pharmacol 1966; 44: 115–128
   PubMed Web of Science ®Google Scholar
• Chang T MS. Artificial Cells. Charles C Thomas Publisher, Springfield 1972; 111
   Google Scholar
• Chang T MS. Nonthrombogenic Microcapsules. 3,522,346, (1970), US patent, Canadian Patent 876,100 (1971). Chang TMS, MacIntosh FC and Mason SG. Encapsulated hydrophilic compositions and methods of making them, Canadian Patent 873,815 (1971). Chang TMS. Blood compatible microcapsules containing detoxicants, US Patent 3,725,113 (1973); Canadian Patent 982,941 (1976). (All assigned to nonprofit organisations Research Co.)
   Google Scholar
• Chang T MS. Microencapsulation and Artificial Cells. Humana Press, Clifton, NJ 1984
   Google Scholar
• Chang T MS. Semipermeable aqueous microcapsules (“artificial cells”): with emphasis on experiments in an extracorporeal shunt system. Trans Amer Soc Artif Internal Organs 1966; 12: 13
   PubMedGoogle Scholar
• Chang T MS. Removal of endogenous and exogenous toxins by a microencapsulated absorbent. Can J Physiol Pharmacol 1969; 47: 1043
   PubMed Web of Science ®Google Scholar
• Chang T MS, Malave N. The development and first clinical use of semiperemable microcapsules (artificial cells) as a compact artificial kidney. Trans Amer Soc Artif Internal Organs 1970; 16: 141
   PubMedGoogle Scholar
• Chang T MS. Microcapsule artificial kidney: including updated preparative procedures and properties. Kidney Int 1976; 10: 218
   Google Scholar
• Chang T MS. Artificial Kidney, Artificial Liver, and Artificial Cells. Plenum Press, New York 1978
   Google Scholar
• Sideman S, Chang T MS. Hemoperfusion: Artificial Kidney and Liver Support and Detoxification, Part I. Hemisphere, Washington, DC 1980
   Google Scholar
• Bonomini V, Chang T MS. Hemoperfusion, Contributions to Nephrology Series. S Karger AG, Basel 1982; 29
   Google Scholar
• Klinkmann H, Falkenhagen D, Courtney J M. Blood purification by hemoperfusion. Int J Artif Organs 1979; 2: 296
   Google Scholar
• Nikolaev V G, Strelko V V. Hemoperfusion. Naukova Dumka, Kiev 1979
   Google Scholar
• Chang T MS, Gonda A, Dirks J H, Malave N. Clinical evaluation of chronic intermittent or short-term hemoperfusions in patients with chronic renal failure using semiperemable microcapsules (artificial cells) formed from membrane-coated activated charcoal. Trans Amer Soc Artif Internal Organs 1971; 17: 246
   PubMedGoogle Scholar
• Chang T MS, Gonda A, Dirks J H, Coffey J F, Burns T. ACAC microcapsule artificial kidney for the long term and short term management of eleven patients with chronic renal failure. Trans Amer Soc Artif Internal Organs 1972; 18: 465–472
   PubMedGoogle Scholar
• Chang T MS, Chirito E, Barre P, Cole C, Hewish M. Clinical performance characteristics of a new combined system for simultaneous hemoperfusion-hemodialysis-ultrafiltration in series. Trans Amer Soc Artif Internal Organs. 1975; 21: 502
   PubMedGoogle Scholar
• Winchester J F, Apiliga M T, Mac Kay J M, Kennedy A C. Short term evaluation of charcoal hemoperfusion combined with dialysis in uremic patients. Kidney Int. 1976; 10: S315
   Web of Science ®Google Scholar
• Stefoni S, Coli L, Feliciangeli G, Baldrati L, Bonomini V. Regular hemoperfusion in regular dialysis treatment A long-term study. Int J Artif Organs. 1980; 3: 348
   PubMedGoogle Scholar
• Chang T MS, Barre P, Kuruvilla S. Long-term reduced time hemoperfusion-hemodialysis compared to standard dialysis: A preliminary cross-over analysis. Trans Amer Soc Artif Intern Organs. 1985; 31: 572
   PubMedGoogle Scholar
• Chang T MS, Chirito E, Barre P, Cole C, Lister C, Resurreccion E. Longterm clinical assessment of combined ACAC hemoperfusionultrafiltration in uremia. Artif Organs. 1979; 3: 127
   PubMedGoogle Scholar
• Chang T MS, Barre P, Kuruvilla S, Messier D, Man M K, Resurreccion E. Phase 1 clinical trial of a new composite artificial kidney combining hemodialysis with hemoperfusion. Trans Amer Soc Artif Internal Organs. 1982; 28: 43
   PubMedGoogle Scholar
• Chang T MS, Coffey J F, Barre P, Gouda A, Dirks J H, Levy M, Lister C. Microcapsule Artificial Kidney: treatment of patients with acute drug intoxication. Canadian Med Assoc J. 1973; 108: 429
   PubMed Web of Science ®Google Scholar
• Chang T MS, Coffey J F, Lister C, Taroy E, Stark A. Methaqualone, methyprylon, and glutethimide clearance by the ACAC microcapsule artificial kidney: in vitro and in patients with acute intoxication. Trans Amer Soc Artif Internal Organs. 1973; 19: 87
   PubMedGoogle Scholar
• Vale J A, Rees A J, Widdop B, Goulding R. The use of charcoal hemoperfusion in the management of severely poisoned patients. British Med J. 1975; 1(5948)5
   Google Scholar
• Poisoning and Drug Overdose, L M Haddad, J F Winchester. WB Saunders Co, Philadelphia 1983
   Google Scholar
• Chang T MS, Espinosa-Melendez E, Francoeur T E, Eade N R. Albumincollodion activated coated charcoal hemoperfusion in the treatment of severe theophylline intoxication in a 3-year-old patient. Pediatrics. 1980; 65: 811
   PubMed Web of Science ®Google Scholar
• Chavers B M, Kjellstrand C M, Wiegand C, Ebben J, Mauer S M. Techniques for use of charcoal hemoeprfusion in infants. Kidney Int. 1980; 18: 386
   PubMed Web of Science ®Google Scholar
• Rosenbaum J L, Raja R. Hemoperfusion in acute intoxication. In Piskin The Past, Present and Future of Artificial Organs, E. TMS Chang. Meteksan Publisher, Ankara, Turkey 1982; 128
   Google Scholar
• Chang T MS, Barre P. Effect of desferrioxamine on removal of aluminium and iron by coated charcoal haemoperfusion and haemodialysis. The Lancet. 1983; Nov: 1051
   Google Scholar
• Chang T MS, Lister C, Varma R. Kinetics of coated charcoal hemoperfusion in the removal of Desferral. In Progress in Artificial Organs, K Atsumi, M Maekawa, K Ota. ISAO Press, Cleveland 1984; 602
   Google Scholar
• Chang T MS. Haemoperfusion over microencapsulated adsorbent in a patient with hepatic coma. Lancet. 1972; ii: 1371–1372
   Google Scholar
• Chang T MS, Migchelsen. Characterization of possible toxic metabolites in uremia and hepatic coma based on the clearance spectrum tor larger molecules by the ACAC microcapsule artificial kidney. Trans Am Soc Artif Intern Organs. 1973; 19: 314
   PubMedGoogle Scholar
• Odaka M, Tabata Y, Kobayashi H, Nomura Y, Soma H, Hirasawa H, Sato H. Clinical experience of bead-shaped charcoal haemoperfusion in chronic renal failure and fulminant hepatic failure. In Artificial Kidney, Artificial Liver, and Artificial Cells, T MS Chang. Plenum Press, New York 1978
   Google Scholar
• Agishi T, Yamashita N, Ota K. Clinical results of direct charcoal hemopertusion for endogenous and exogenous intoxication. In Hemoperfusion: Kidney and Liver Support and Detoxification, Part I, S Sideman, T MS Chang. Hemisphere, Washington 1980
   Google Scholar
• Geltand M C, Winchester J F, Knepshield J H, Cohan S L, Schreiner G E. Biochemical correlates of reversal of hepatic coma with coated charcoal hemoperfusion. Trans Amer Soc Artif Intern Organs. 1978; 24: 239
   Google Scholar
• Artificial Liver Support, K Williams, I M Murrary-Lyon. Pitman, London 1975
   Google Scholar
• Chirito E, Keiter B, Lister C, Chang T MS. Artificial Liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure. Artif Organs 1977; 1(1)76
   PubMedGoogle Scholar
• Chang T MS, Lister C, Chirito E, O'Keefe P, Resurreccion E. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats. Trans Amer Soc Artif Internal Organs. 1978; 24: 243
   PubMedGoogle Scholar
• Tabata Y, Chang T MS. Comparisons of six artificial liver support regimes in fulminant hepatic coma rats. Trans Amer Soc Artif Internal Organs. 1980; 26: 394
   PubMedGoogle Scholar
• Gimson A ES, Braude S, Mellon P J, Canalese J., Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet. 1982; Sept. 25: 681
   Google Scholar
• Shi Z Q, Chang T MS. Effects of hemoperfusion on blood and brain levels of tyrosine and middle molecules. Trans Amer Soc Artif Internal Organs. 1982; 28: 205
   PubMedGoogle Scholar
• Chang T MS, Yu Y T, Grunwald J. Artificial cells immobilized multienzyme systems and cofactors. Enzyme Engineering. 1982; 16: 451
   Google Scholar
• Chang T MS. Artificial cells with regenerating multienzyme systems methods in Enzymology. 1985; 112: 195
   PubMed Web of Science ®Google Scholar
• Gu K F, Chang T MS. Artificial cells with multienzyme systems for conversion of ammonia and urea into leucine, isoleucine and valine. J Biomat Artificial Cells and Artificial Organs 1987; 15, (this issue)
   Google Scholar
• Bourget L, Chang T MS. Phenylaianine ammonia-lysase immobilized in semipermeable microcapsules for enzyme replacement in phenylketonuria. Fed of Europ Biochem Soc (FEBS Letters) 1985; 180: 5
   PubMed Web of Science ®Google Scholar
• Bourget L., Chang T MS. Phenylalanive ammonia lysase immobilised in semipermeable microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model. Biochim Biophys Acta. 1986; 883: 432–438
   PubMed Web of Science ®Google Scholar
• Lemieux R U. Synthetic adsorbent for anti-A or anti-B antibodies. Chem Soc Rev. 1978; 7: 423
   Web of Science ®Google Scholar
• Chang T MS. Blood compatible coating of synthetic immunoadsorbents. Trans Amer Soc Artif Internal Organs. 1980; 26: 546
   PubMedGoogle Scholar
• Bensinger W I, Bucker C D, Clift R A. Whole blood immunoadsorption of anti-A or anti-B antibodies. Vox Sang. 1985; 48: 357
   Google Scholar
• Gardner D L, Falb R D, Kim B C, Emmerling D C. Possible uremic detoxification via oral ingested microcapsules. Trans Amer Soc Artif Intern Organs. 1971; 17: 239
   PubMedGoogle Scholar
• Kjellstrand C, Borges H, Pur C, Gardner U, Fink U. Ureasezirconiumphosphate microcapsules (UZP) effectively decreases nitrogen accumulation in CRF patients. (Abstract) Am Soc Artif Intern Organs. 1981; 10: 47
   Google Scholar
• Lim F, Sun A N. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908
   PubMed Web of Science ®Google Scholar
• Damon Corporation. Tissue Microencapsulation. Needham Heights, Mass 1981
   Google Scholar
• Wong H, Chang T MS. Bioartificial liver: artificial cells microencapsulated hepatocytes increases survival of liver failure rats. Int J Artit Organs. 1986; 9: 335
   PubMed Web of Science ®Google Scholar
• Chang T MS. Artificial red blood cells. Trans Amer Soc Artif Internal Organs. 1980; 2b: 354
   Google Scholar
• Keipert P E, Minkowitz J, Chang T MS. Cross-linked stroma-free polyhemoglobin as a potential blood substitute. Int J Artif Organs. 1982; 5: 383
   PubMed Web of Science ®Google Scholar
• Benesch R, Benesch R E, Yung S, Edalji R. Hemoglobin covalently bridged across polyphosphate binding site. Biochem Biophs Res Commun. 1975; 63: 1123
   PubMed Web of Science ®Google Scholar
• Sehgal L K, Gould S A, Rosen A L, Sehgal H L, Moss G S. Polymerized pyridoxalated hemoglobin. Surgery. 1984; 95: 433
   PubMed Web of Science ®Google Scholar
• Bolin R B, Geyer R P, Nemo G J. Advances in Blood Substitute Research. A.R. Liss Inc, New York 1983
   Google Scholar
• Keipert P E, Chang T MS. In vivo asessment of pyridoxylated cross-linked polyhemoglobin as an artificial red cell substitute in rats. Trans Amer Soc Artif Internal Organs. 1983; 29: 329
   PubMedGoogle Scholar
• Chang T MS. The future potentials of blood substitutes in transfusion. Transplantation Today. 1985; Sept: 40
   Google Scholar
• Keipert P E, Chang T MS. Pyridoxylated polyhemoglobin as a blood substitute for resuscitation of lethal hemorrhagic shock in conscious rats. Biomat, Med Dev, and Artif Organs. 1985; 13: 1
   PubMedGoogle Scholar
• Geyer R P, Monroe R G, Taylor K. Survival of rats totally perfused with a fluorocarbon-detergent preparation. In: Organ Perfusion and Preservation, J C Norman, F Folkman. Appleton Century Crofts, New York 1968; 85
   Google Scholar
• Abstracts IIIrd International Symposium on Blood Substitutes. J Biomaterial. Artificial Cells and Artificial Organs. 1987, (in press)
   Google Scholar
• Proceeding, IIIrd International Symposium on Blood Substitutes (for), T MS Chang, R. Geyer. 1988
   Google Scholar